The effect of a rabbit antibody induced against the rat insulin receptor (RAR) was tested using cultured 3T3-L1 fat cells. As previously seen with antibodies against the insulin receptor from patients with the type B syndrome of insulin resistance and acanthosis nigricans, RAR acutely mimicked the action of insulin by stimulating deoxyglucose uptake. After prolonged exposure of 3T3-L1 cells to RAR, insulinomimetic activity was lost and the cells became resistant to the action of insulin. This state of insulin resistance is similar to that seen with the human autoantibodies. However, unlike antibody from the patients, RAR did not acutely inhibit the binding of insulin to its receptor; rather, RAR increased the binding of insulin to its receptor by a mechanism consistent with an increase in the affinity of the receptor for insulin. With prolonged exposure to RAR there was a dramatic decrease in insulin-receptor binding on the treated 3T3-L1 fat cells. These results suggest that antibody against the insulin receptor induces insulin resistance by a mechanism that involves loss of cell-surface insulin receptors.
Antibodies directed against the insulin receptor are found in the antiserum of patients with the type B syndrome of insulin resistance and acanthosis nigricans (HAR) (1, 2) . Such patients show a marked decrease in the binding of insulin to circulating monocytes (2) . When studied acutely in vitro, HAR was shown to inhibit the binding of insulin to its receptor but also to mimic all of the known actions of insulin (1, 3) .
A model for the induction of insulin resistance by these anti-receptor autoantibodies has been developed using 3T3-Li fat cells maintained in tissue culture (4, 5) . As in other tissues, HAR acutely mimics the action of insulin in 3T3-L1 cells but, with prolonged exposure to HAR in culture, the insulinomimetic activity disappears and the cells are rendered resistant to the actions of insulin (4, 5) . This does not represent simple "down-regulation," as 3T3-L1 cells studied under these conditions do not down-regulate in response to insulin (6) . Because HAR also acutely inhibits the binding of insulin to its receptor, it has not been possible to follow the fate of the insulin receptor during antibody-induced insulin resistance. When cells are treated with saturating amounts of HAR, no difference is seen between the acute inhibition of binding and the residual binding after the induction of insulin resistance (4) . Hence, for lack of a clear mechanism, this process was termed "antibody-induced desensitization of the insulin receptor." The process was shown to be time and temperature dependent but was not inhibited by a variety of inhibitors of specific cell functions (5) .
This paper examines the effect of an antibody raised in rabbits against the rat hepatic insulin receptor (RAR) that does not acutely inhibit the binding of insulin to its receptor (7, 8) . (Rockville, MD) . Rabbit antiserum produced against RAR was provided by Steven Jacobs (Burroughs-Wellcome) (7, 8) . RAR and control serum were used after heat inactivation. HAR was obtained from two patients with the type B syndrome of insulin resistance and acanthosis nigricans (National Institutes of Health patients B-2 and B-8) and was partially purified as described (4).
3T3-L1 cells were provided by Howard Green (Massachusetts Institute of Technology). The cells were grown in Dulbecco-Vogt modified Eagle's medium containing 10% fetal calf serum (DV medium) as described (6) . Differentiation was induced by treating confluent cells for 2 days with DV medium, supplemented with 0.5 mM 1-methyl-3-isobutylxanthine/0.25 ,tM dexamethasone/insulin (1 ,ig per ml) as described (9 (4, 9) . 125I-labeled insulin was prepared by modification of the chloramine-T method to a specific activity of gCi/mg or -0.5 iodine per insulin (10) . Cells were incubated with 12 I-labeled insulin (50 pM) under conditions identical to those of the deoxyglucose-uptake assay, except that the incubation was carried out for 70 min in 1 x KR buffer. The cells were then washed with Dulbecco's phosphate-buffered saline and prepared for gamma counting as described (4, 9) .
Densensitization Protocol. For desensitization, cells were exposed to antibody against the insulin receptor or control serum in DV medium for 7 hr at 370C in a 5% C02/95% air incubator. Cells were then rinsed and insulin binding or insulin action was studied in KR buffer as described above. This protocol is identical to that used previously when studying HAR from patients with the type B syndrome of insulin resistance and acanthosis nigricans (4, 5) . RESULTS
The Acute Effects of Rabbit Anti-receptor Antibody on Insulin Action. As previously seen with other cell types, RAR acutely mimicked the action of insulin in 3T3-L1 cells. After a 20-min incubation at 220C, both RAR and HAR from patient B-8 were able to stimulate deoxyglucose uptake to the same extent as insulin (Fig. 1 ). Control serum had no effect on deoxyglucose uptake at these dilutions (data not shown).
The Effect of Prolonged Exposure of 3T3-L1 Cells to RAR on Insulin Action. 3T3-L1 cells were exposed to either RAR or HAR from patients B-2 or B-8 for 7 hr at 370C. When basal deoxyglucose uptake was then measured, the insulinomimetic activity had disappeared (Fig. 2, open bars) . In addition, after this prolonged exposure to either RAR or HAR, insulin was no longer able to stimulate deoxyglucose uptake in the treated 3T3-L1 cells (hatched bars). Thus, RAR caused a In fact, when 3T3-L1 cells were acutely exposed to RAR, tracer insulin binding increased (Fig. 3, Inset) . The maximal increase in insulin binding was seen at an antibody titer of 1:100, similar to that required for the maximal stimulation of deoxyglucose uptake by RAR (data not shown). In several experiments, the increase in insulin tracer binding varied from 220% to 350% of control. The effect of RAR on insulin binding was then analyzed by means of a Scatchard plot (Fig. 3) . The binding of insulin to its receptor on RARtreated cells was increased at low concentrations of insulin but approached that of control cells at higher concentrations. This is consistent with RAR acutely increasing insulin binding by increasing the affinity of the receptor for insulin.
The Effect of Prolonged Exposure to RAR on Insulin Binding. To determine the fate of the insulin receptor during the induction of insulin resistance by RAR, cells were exposed in culture to RAR for 7 hr in DV medium at 37°C, a time sufficient to induce insulin resistance. Prolonged exposure to increasing amounts of RAR led to a decrease in tracer insulin binding (Fig. 4, Inset) . When the decrease in binding was analyzed by a Scatchard plot (Fig. 4) , the data were consistent with a decrease in insulin receptor number.
DISCUSSION
In this paper, the effects of acute and prolonged exposure of 3T3-L1 cells to rabbit antibody against the insulin receptor were studied. During acute treatment, RAR mimicked the action of insulin, having the same maximal effect as insulin or HAR on stimulating deoxyglucose uptake. The concentration of RAR required for stimulation of deoxyglucose uptake (14, 15) . The effect of prolonged exposure to RAR on insulin binding. Cells were exposed to control serum (e) or to RAR (o) at a dilution of 1:100 in DV medium for 7 hr at 37TC. Cells were then rinsed in 0.25x KR buffer and insulin binding was measured as in Fig. 3 . (Inset) Cells were incubated in the absence or presence of increasing amounts of RAR in DV medium for 7 hr at 370C; tracer insulin binding was then measured using '25I-labeled insulin as described in Fig. 3. "Klotz" plots (data not shown), a change in receptor number cannot be ruled out. Alternatively, this increase in binding may be a reflection of differences in internalization (16 (19) reported that insulin can cause receptor down-regulation when 3T3-L1 cells are retreated with insulin within 24 hr of removal of the insulin-containing medium used for differentiation; this corresponds to the period when insulin receptor number is "upregulating" during differentiation to the adipocyte phenotype. Second, the insulin resistance seen in type B patients far exceeds that which can be attributed to down-regulation in hyperinsulinemic states (2) . Finally, antibody-induced desensitization does not resemble insulin-induced down-regulation, as it occurs faster and is not inhibited by cycloheximide (4). However, it is not yet clear whether the loss of insulin receptors causes the desensitization to insulin or whether the insulin receptor is first inactivated and then lost.
Antibodies against the cholinergic receptor in myasthenia gravis decrease the number of cholinergic receptors by increasing the cellular degradation rate of the receptor (20) .
Antibodies against the insulin receptor could work by a similar mechanism; alternatively, they might induce internalization without degradation or cause shedding of the receptor into the medium. Although we cannot distinguish between these possibilities at this time, it is of note that HAR requires bivalence in order to induce insulin resistance (5) ; antibodies against the cholinergic receptor increase receptor degrada-2510 Medical Sciences: Grunfeld Proc. Natl. Acad. Sci. USA 81 (1984) 2511 tion by a cross-linking process that also requires bivalence (20) .
In conclusion, RAR was used in cultured fat cells to induce a state of insulin resistance similar to that induced by HAR from patients with the type B syndrome of insulin resistance and acanthosis nigricans. These studies indicate that the induction of insulin resistance by anti-receptor antibody is not dependent on the acute inhibition of insulin binding that is usually seen with anti-receptor antibodies from humans. Moreover, the induction of insulin resistance by RAR was accompanied by the loss of cell-surface insulinreceptor binding. A similar mechanism may be responsible for the insulin resistance seen in the type B syndrome of insulin resistance and acanthosis nigricans.
Note Added in Proof. Since this ma iuscript was submitted, Roth et al. (21) and Taylor and Marcus-Samuels (22) have shown that antibodies against the insulin receptor cause down regulation of the insulin receptor in IM-9 cells.
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